Dr Sherry Yang is Physician and Chief of National Clinical Target Validation Laboratory, Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI), Bethesda, Maryland, United States. Dr Yang joined NCI in 2001 after completion of her training from the Johns Hopkins Oncology Center, Baltimore, Maryland. Her research interests include clinical target validation and biomarker science towards precision medicine. Dr Yang’s laboratory focuses on the predictive and prognostic biomarkers of targeted cancer therapeutics and chemotherapy in breast cancer, lung cancer and other cancer types. She is recipient of several biomarkersrelated innovation awards, and an editor of the Handbook of Therapeutic Biomarkers in Cancer, 2nd edition.